Stock Analysis

Links to stories that analyze a company's stock.

Revised deal demonstrates Sprue's strength

(via www.iii.co.uk)

The extension of smoke alarm manufacturer Sprue Aegis's agreement to distribute US rival BRK's products is anything but routine and reveals the company's growing strength.
read more

Advertisement:

Advertisement:

Advertisement:

Xaar: Always looking forward

(via www.iii.co.uk)

Widely fancied digital inkjet printhead manufacturer Xaar has gained a dominant position supplying manufactures that make printers for the decorative ceramic tile industry. The investment case depends on digitising other industries too.
read more

Advertisement:

Advertisement:

Brainjuicer's behavioural advantage

(via www.iii.co.uk)

Market researcher BrainJuicer is a resoundingly profitable company that rebounded in 2013 from an uncharacteristically poor 2012. The main question for long term-investors is not whether it has advantages, it's whether they will last.
read more

Advertisement:

Advertisement:

Dividend Growth Stocks: Exxon Mobil Corporation (XOM) Dividend Stock Analysis

(via www.dividend-growth-stocks.com)

Exxon Mobil Corp., formed through the merger of Exxon and Mobil in late 1999, is the world's largest publicly owned integrated oil company. Linked here is a detailed analysis and commentary...

Nichols: a bittersweet investment

(via www.iii.co.uk)

The manufacturer of Vimto is a financial fortress. Resoundingly profitable and stuffed with cash, the company would have an unassailable future if it weren't for the demonisation of its second most important ingredient: sugar.
read more

Advertisement:

Diversification..again..

(via www.oddballstocks.com)

I often get asked the question "what are your thoughts on diversification?"  Someone asked me recently and I thought that newer readers might appreciate my thoughts on it as well.  I wrote about this a year and a half ago, the post generated some lively comments, and I expect this one...

Advertisement:

Zotefoams sags, confidence doesn't

(via www.iii.co.uk)

Zotefoams full-year results were disappointing, but the market's reaction was far from disappointed. That may be because, longer-term, the foam manufacturer has very attractive qualities.
read more

Advertisement:

FW Thorpe interims herald return to growth

(via www.iii.co.uk)

After a modest contraction in 2013, lighting manufacturer and Share Sleuth portfolio member FW Thorpe's half-year results published yesterday herald a return to growth as the adoption of LED lighting continues.
read more

Advertisement:

Dividend Growth Stocks: Abbvie Inc. (ABBV) Dividend Stock Analysis

(via www.dividend-growth-stocks.com)

Abbvie Inc. is a global research-based pharmaceuticals business that emerged as a separate entity following its spin-off from Abbott Laboratories at the start of 2013. AbbVie's key drug is Humira for rheumatoid arthritis. Linked here is a detailed analysis and commentary...

Advertisement:

Share Sleuth Digest: The shape of things to come

(via www.iii.co.uk)

Northgate and Tristel update the market, Watchlist  companies Treatt, Fenner, and Animalcare enter value territory, and an academic paper shows "charts are pants".

read more

Defy Putin by Making a 50% Return on this Russian Media Stock

(via www.magicdiligence.com)

Take advantage of the turmoil in the Ukraine by investing in CTC Media, one of the largest television broadcasting networks in Russia, at what looks to be a 50% discount to fair value.

Advertisement:

2015: Pearson's Educational Odyssey

(via www.iii.co.uk)

To invest in Pearson you have to believe two things, demand for learning materials and services in the UK and US will pick up, and costly restructuring and investment to make the business more educational, more digital, more international, and more service oriented will pay off.
read more

Advertisement:

24 Best Small Cap Ideas for 2014

(via valuestockguide.com)

Small cap screen looking for best valuations available today.

Publishing Technology's slow advance

(via www.iii.co.uk)

The most revealing section of software company Publishing Technology's annual report is the segmental analysis, which reveals the future has yet to arrive. If it does, the business will be transformed.
read more

Calling all risk takers, a Ukrainian investment at 2x earnings and 45% of book value

(via www.oddballstocks.com)

"The time to buy is when there's blood in the streets." - Baron Rothschild
Investors who venture into risky markets can realize either fantastic returns, or encounter losses to be written off at tax time.  Right now feels like one of those times where a fortune could be made or lost by...

Advertisement: